Eating Disorder Safe principles

See also

Eating Disorders and GLP-1 RAs

Glucagon-like peptide-1receptor agonists (GLP-1 RAs), such as semaglutide (Ozempic), are medications originally developed to treat type 2 diabetes.

Read more

Evaluating the Risk of Harm of Weight-Related Public Messages

Campaigns and resources that provide weight-related messages may lead to unintended consequences.

Read more

NEDC Eating Disorders: key considerations for service providers

NEDC is dedicated to developing and implementing a nationally consistent, evidence-based system of care for the prevention and treatment of eating disorders.

Read more

Issue 37 | Evidence-Based Practice

NEDC e-Bulletin Issue 37 Editor’s Note Welcome to the thirty-seventh edition of the NEDC e-Bulletin.

Read more